Denali Therapeutics (DNLI) Other Non-Current Liabilities (2017 - 2025)
Denali Therapeutics (DNLI) posted Other Non-Current Liabilities of $4.04 million for Q3 2025, up 2.4% from $3.94 million a year earlier but down 61.3% from the prior quarter.
Powered by 
Analysis
Denali Therapeutics (DNLI) Other Non-Current Liabilities (2017 - 2025) Analysis & Trends
At the end of FY2022, Denali Therapeutics' Other Non-Current Liabilities came in at $379,000, unchanged from FY2021.
- Annual Other Non-Current Liabilities shows a five-year compound annual growth rate of -43.0% (FY2017 to FY2022).
- In prior years, Denali Therapeutics' Other Non-Current Liabilities was $379,000 in FY2021 (-45.9%), $701,000 in FY2020 (+85.0%), $379,000 in FY2019 (-98.5%) and $24.53 million in FY2018 (+289.8%).
- Quarterly Other Non-Current Liabilities has run from a low of $379,000 in Q4 2021 to a high of $16.73 million in Q1 2025 over five years.
- The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was Q3 2024, with growth of 940.6%; the weakest was Q4 2021, with a decline of 45.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Denali Therapeutics | 3.30 Bn | 3.30 Bn | 3.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 4.04 Mn |
| Jun 30, 2025 | 10.44 Mn |
| Mar 31, 2025 | 16.73 Mn |
| Sep 30, 2024 | 3.94 Mn |
| Sep 30, 2023 | 379,000.00 |
| Jun 30, 2023 | 379,000.00 |
| Mar 31, 2023 | 379,000.00 |
| Dec 31, 2022 | 379,000.00 |
| Sep 30, 2022 | 379,000.00 |
| Jun 30, 2022 | 379,000.00 |
| Mar 31, 2022 | 379,000.00 |
| Dec 31, 2021 | 379,000.00 |
| Sep 30, 2021 | 701,000.00 |
| Jun 30, 2021 | 701,000.00 |
| Mar 31, 2021 | 701,000.00 |
| Dec 31, 2020 | 701,000.00 |
| Sep 30, 2020 | 379,000.00 |
| Jun 30, 2020 | 379,000.00 |
| Mar 31, 2020 | 379,000.00 |
| Dec 31, 2019 | 379,000.00 |
API Access
Denali Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=DNLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "DNLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=DNLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();